We identified an association between the T allele at rs12203592 (typed) in IRF4 and an increased risk for the development of de novo AML, de novo MDS and t-MDS in patients who had undergone URD-BMT compared to healthy donor controls. Here, IRF4 is linked to myelodysplastic syndrome.